why choose us

First received: December 12, 2023

Clinical Trial: A Study to Learn How Safe, Tolerable and Capable of Producing an Immune Response is, a Modified RNA Vaccine Against Pandemic Influenza

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Grippe

Study Type: INTERVENTIONAL


Official Title: A PHASE 1, RANDOMIZED, OBSERVER-BLIND, DOSE-RANGING STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF MODIFIED RNA VACCINE CANDIDATES AGAINST PANDEMIC INFLUENZA IN HEALTHY INDIVIDUALS

Brief Summary: The purpose of this study is to learn about the safety and effects of the study vaccine for the possible prevention of influenza.Influenza is a disease that can spread easily from one person to another and cause body aches, fever, cough, and other symptoms.The study vaccine is called Pandemic Influenza modRNA (pdmFlu) Vaccine.This study is seeking for participants who are:between the age of 18 to 49 years old.willing and able to follow with all scheduled visits, treatment plan, laboratory tests, lifestyle changes,…

Read more